Trialect

Active

Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees

National Institutes of Health

This Notice encourages eligible NINDS awardees in the Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) research community to apply for administrative supplements in response to PA-23-189 , "Research Supplements to Promote Diversity in Health-Related Research)," or any reissues of this announcement through the expiration date of this Notice. The NIH has a strong interest in the diversity of the NIH-funded workforce (see NOT-OD-20-031 , "Notice of NIH's Interest in Diversity") and encourages institutions to diversify their student populations by enhancing the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral, and social sciences. Goal 1 of the National Plan to Address Alzheimer’s Disease is to prevent and effectively treat AD/ADRD. This initiative addresses the critical need to increase the number of health professionals and researchers who are trained to meet the expanding demand for cognitive impairment and dementia diagnosis, care, and research to meet Goal 1.

Program Directors/Principal Investigators (PD/PI) of active ADRD research grants are encouraged to consider administrative supplements under this program at the following career levels: high school students, undergraduate students, baccalaureate and master’s degree holders, graduate (predoctoral) and health professional students, individuals in postdoctoral training, and investigators developing independent research careers. All applications must include a signed statement from an institutional official establishing the eligibility of the candidate for the program, including information about the citizenship of the candidate, and a description of how the candidate would further the goals of the program, consistent with NOT-OD-20-031 , "Notice of NIH's Interest in Diversity". The activities proposed in the supplement application must fall within the scope and advance the objectives of the parent grant, and support the research experience and professional development of the supplement candidate.

Diversity supplement awardees, as appropriate for the duration of their support and career stage, may request funds, in addition to the research costs specified in PA-23-189 (or any reissues of this announcement), to enable the supplement candidate to attend the AD/ADRD research and care summits. This request for additional funds should be reasonable and well justified in the application.

Before submitting an application, applicants are strongly encouraged to consult with the Program Official for the parent grant to confirm eligibility and to obtain technical assistance.

Application Due Date(s): All applications are due by 5:00 PM local time of application organization to due dates on or after May 15, 2024 and subsequent receipt dates through Feb 15, 2027.

Application Receipt Window

August 1 to November 15

November 16 to February 15

February 16 to May 15

NOT-NS-24-071